CA1224461A - Antibiotic compound, a method for its preparation and compositions containing it - Google Patents

Antibiotic compound, a method for its preparation and compositions containing it

Info

Publication number
CA1224461A
CA1224461A CA000471563A CA471563A CA1224461A CA 1224461 A CA1224461 A CA 1224461A CA 000471563 A CA000471563 A CA 000471563A CA 471563 A CA471563 A CA 471563A CA 1224461 A CA1224461 A CA 1224461A
Authority
CA
Canada
Prior art keywords
erythromycin
stearate
acetyl
ester
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000471563A
Other languages
English (en)
French (fr)
Inventor
Martti Marvola
Esko Marttila
Pekka Kairisalo
Jaakko Uotila
Aino Pippuri
Erkki Honkanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Application granted granted Critical
Publication of CA1224461A publication Critical patent/CA1224461A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
CA000471563A 1984-01-06 1985-01-04 Antibiotic compound, a method for its preparation and compositions containing it Expired CA1224461A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
DK58/84 1984-01-06

Publications (1)

Publication Number Publication Date
CA1224461A true CA1224461A (en) 1987-07-21

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000471563A Expired CA1224461A (en) 1984-01-06 1985-01-04 Antibiotic compound, a method for its preparation and compositions containing it

Country Status (38)

Country Link
US (1) US4599326A (en:Method)
JP (1) JPS60158197A (en:Method)
KR (1) KR900006237B1 (en:Method)
AT (1) AT386414B (en:Method)
AU (1) AU565688B2 (en:Method)
BE (1) BE901411A (en:Method)
BG (1) BG43189A3 (en:Method)
CA (1) CA1224461A (en:Method)
CH (1) CH666275A5 (en:Method)
CS (1) CS247191B2 (en:Method)
CY (1) CY1462A (en:Method)
DE (1) DE3500179A1 (en:Method)
DK (1) DK149776C (en:Method)
ES (1) ES8605818A1 (en:Method)
FI (1) FI77249C (en:Method)
FR (1) FR2557878B1 (en:Method)
GB (1) GB2152502B (en:Method)
HK (1) HK11590A (en:Method)
HU (1) HU196221B (en:Method)
IE (1) IE57967B1 (en:Method)
IL (1) IL73885A (en:Method)
IS (1) IS2968A7 (en:Method)
IT (1) IT1184304B (en:Method)
KE (1) KE3841A (en:Method)
LU (1) LU85721A1 (en:Method)
MA (1) MA20316A1 (en:Method)
MX (1) MX156277A (en:Method)
NL (1) NL8403979A (en:Method)
NO (1) NO160263C (en:Method)
NZ (1) NZ210606A (en:Method)
PH (1) PH22471A (en:Method)
PL (1) PL144349B1 (en:Method)
PT (1) PT79777B (en:Method)
RO (1) RO91262B (en:Method)
SE (1) SE461854B (en:Method)
SU (1) SU1410866A3 (en:Method)
YU (1) YU44485B (en:Method)
ZA (1) ZA8410143B (en:Method)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US20050158374A1 (en) * 2003-10-31 2005-07-21 Wong Patrick S. Compositions and dosage forms for enhanced absorption of metformin
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
EP2457580A1 (en) 2004-08-25 2012-05-30 The UAB Research Foundation Absorption enhancers for drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
CA2743725A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
AU2012255116B2 (en) 2011-05-18 2017-05-25 Mederis Diabetes, Llc Improved peptide pharmaceuticals
WO2014081864A1 (en) 2012-11-20 2014-05-30 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
KR102213907B1 (ko) 2012-11-20 2021-02-09 메더리스 다이어비티즈, 엘엘씨 인슐린 저항성에 대한 개선된 펩티드 약제
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
CN117180445A (zh) 2014-05-28 2023-12-08 梅德瑞斯糖尿病有限责任公司 针对胰岛素抵抗的改良肽药物
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
RU2019142102A (ru) 2017-05-19 2021-06-21 Лунелла Байотек, Инк. Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
ES2791775B2 (es) 2018-02-06 2023-01-20 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
US11918597B2 (en) * 2018-12-17 2024-03-05 Lunella Biotech, Inc. Triple combination therapies for anti-aging
WO2020131696A1 (en) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Triple combination therapies for targeting mitochondria and killing cancer stem cells
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FI850023A0 (fi) 1985-01-03
AT386414B (de) 1988-08-25
SE8406671D0 (sv) 1984-12-28
NO160263B (no) 1988-12-19
JPS60158197A (ja) 1985-08-19
PL144349B1 (en) 1988-05-31
SE8406671L (sv) 1985-07-07
DK149776C (da) 1987-04-21
IL73885A (en) 1988-10-31
FI77249C (fi) 1989-02-10
AU3705984A (en) 1985-07-11
PH22471A (en) 1988-09-12
IE850022L (en) 1985-07-06
FI77249B (fi) 1988-10-31
IE57967B1 (en) 1993-06-02
GB2152502B (en) 1987-10-07
HK11590A (en) 1990-02-23
KR900006237B1 (ko) 1990-08-27
CH666275A5 (de) 1988-07-15
BE901411A (fr) 1985-04-16
DE3500179A1 (de) 1985-07-18
ES8605818A1 (es) 1986-04-01
BG43189A3 (en) 1988-04-15
MX156277A (es) 1988-08-04
NZ210606A (en) 1987-08-31
JPH029040B2 (en:Method) 1990-02-28
IT8519012A0 (it) 1985-01-04
RO91262B (ro) 1987-07-01
ZA8410143B (en) 1985-08-28
US4599326A (en) 1986-07-08
NO850007L (no) 1985-07-08
YU44485B (en) 1990-08-31
CS247191B2 (en) 1986-12-18
ATA985A (de) 1988-01-15
SU1410866A3 (ru) 1988-07-15
HU196221B (en) 1988-10-28
DK5884D0 (da) 1984-01-06
FR2557878A1 (fr) 1985-07-12
GB2152502A (en) 1985-08-07
DK5884A (da) 1985-07-07
MA20316A1 (fr) 1985-10-01
RO91262A (ro) 1987-06-30
DE3500179C2 (en:Method) 1989-08-24
FR2557878B1 (fr) 1988-01-15
CY1462A (en) 1989-07-21
HUT37628A (en) 1986-01-23
ES539349A0 (es) 1986-04-01
PT79777B (en) 1986-10-21
YU2085A (en) 1987-12-31
NL8403979A (nl) 1985-08-01
SE461854B (sv) 1990-04-02
KR850005452A (ko) 1985-08-26
NO160263C (no) 1989-03-29
PT79777A (en) 1985-01-01
IS2968A7 (is) 1985-04-03
KE3841A (en) 1989-04-07
DK149776B (da) 1986-09-29
GB8432368D0 (en) 1985-02-06
AU565688B2 (en) 1987-09-24
PL251457A1 (en) 1985-11-05
LU85721A1 (fr) 1985-07-24
IL73885A0 (en) 1985-03-31
FI850023L (fi) 1985-07-07
IT1184304B (it) 1987-10-28

Similar Documents

Publication Publication Date Title
CA1224461A (en) Antibiotic compound, a method for its preparation and compositions containing it
DK175544B1 (da) Anvendelse af azithromycin og derivater deraf til fremstilling af antiprotozoale lægemidler
RU2478643C2 (ru) Макроциклические полиморфы, композиции, содержащие такие полиморфы, и способы их применения и получения
US4022889A (en) Therapeutic compositions of antibiotic U-44,590 and methods for using the same
DE2029768C2 (de) Antitumorverbindung 593A, Verfahren zu ihrer Herstellung und Arzneimittel
JP2628368B2 (ja) 高純度ラクチュロース粉末の製造法ならびにラクチュロースを含むビフイズス菌製剤の製造法
JPH0317840B2 (en:Method)
EP0076066B1 (en) Penicillin derivatives
JPS6234038B2 (en:Method)
EP0369503B1 (en) Method for the control of pneumocystis carinii
PL98718B1 (pl) Sposob wytwarzania nowego antybiotyku antibioticum bay g 7299
JPH1129465A (ja) 抗潰瘍剤
JP2780828B2 (ja) ポリエーテル抗生物質ｍｉ２１５―ｎｆ３物質及びその製造法、並びに鶏のコクシジウム症の防除剤
Nel et al. Cardiac glycoside poisoning in sheep caused by Urginea physodes (Jacq.) Bak. and the isolated physodine A
JPS5849386A (ja) セフアロスポリン誘導体及び該誘導体を含有する医薬
JPH07289273A (ja) ナフトキノン誘導体
NO143030B (no) Fremgangsmaate for fremstilling av polyeter-antibiotikumblandingen a-28086 eller dens bestanddeler faktor a, faktor b og faktor d
JPS59128388A (ja) セフアロスポリン誘導体及び該誘導体を含有する薬剤
JPS5950318B2 (ja) 新規抗生物質ｓｙ−２物質
PL87225B1 (en:Method)
JPS59128390A (ja) セフアロスポリン誘導体及び該誘導体を含有する薬剤
DD231796A5 (de) Antibiotische verbindungen, herstellungsverfahren und zusammensetzungen, die diese stoffe enthalten
JPS6332794B2 (en:Method)
PT92525A (pt) Processo para a preparacao de um complexo de compostos glicopeptidicos
JPS59118793A (ja) セフアロスポリン誘導体及び該誘導体を含有する医薬

Legal Events

Date Code Title Description
MKEX Expiry